✨ Medicines and Social Services Notices
NEW ZEALAND GAZETTE, No. 87 — 6 AUGUST 2015
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
BeneFIX
Nonacog alfa 3000IU
Injection with diluent
Pfizer New Zealand Limited
Wyeth Farma SA, Madrid, Spain
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Neutroval
Filgrastim 600mcg/mL
Solution for injection
Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Teva Pharmaceutical Industries Limited, Kfar Saba, Israel
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Xergic
Fexofenadine hydrochloride 120mg
Film coated tablet
Mylan New Zealand Limited
Dr Reddy’s Laboratories Limited, Andhra Pradesh, India
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Xergic
Fexofenadine hydrochloride 180mg
Film coated tablet
Mylan New Zealand Limited
Dr Reddy’s Laboratories Limited, Andhra Pradesh, India
Dated this 31st day of July 2015.
CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
2015-go4582
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Onglyza
Saxagliptin hydrochloride 2.98mg equivalent to Saxagliptin 2.5mg
Film coated tablet
AstraZeneca Limited
Bristol-Myers Squibb Company, Indiana, United States of America
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
Onglyza
Saxagliptin hydrochloride 5.95mg equivalent to Saxagliptin 5mg
Film coated tablet
AstraZeneca Limited
Bristol-Myers Squibb Company, Indiana, United States of America
Dated this 31st day of July 2015.
CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
2015-go4583
Notice of Revocation of Approval of a Child and Family Support Service and Community Social Service
The Director Approvals, Community Investment, Ministry of Social Development, gives notice that the approval of Raukura Waikato Social Services Trust as a child and family support under section 396, and as a community service under section 403 of the Children, Young Persons, and Their Families Act 1989 is revoked effective as of 28 July 2015.
Dated this 30th day of July 2015.
58
Next Page →
✨ LLM interpretation of page content
🏥 Consent to the Distribution of New Medicines
🏥 Health & Social Welfare31 July 2015
Medicines Act 1981, new medicines, distribution consent, BeneFIX, Neutroval, Xergic
- CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health
🏥 Consent to the Distribution of New Medicines
🏥 Health & Social Welfare31 July 2015
Medicines Act 1981, new medicines, distribution consent, Onglyza
- CHRIS JAMES, Acting Group Manager, Medsafe, Ministry of Health
🏥 Notice of Revocation of Approval of a Child and Family Support Service and Community Social Service
🏥 Health & Social Welfare30 July 2015
Children, Young Persons, and Their Families Act 1989, revocation, Raukura Waikato Social Services Trust
- Director Approvals, Community Investment, Ministry of Social Development
NZ Gazette 2015, No 87